Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

Researchers have found that a small vaccine, currently in its early trial phase, can enhance immune system response to fight ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

A phase 1 trial of a personalized cancer vaccine for stage III/IV clear cell renal cell carcinoma showed promising results.

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...